CancerScan

[CancerScan @CancerScan_EU]

🧠 Why do some treatments stop working?

Part of the answer lies in the constant communication between tumour cells and their surroundings.

🔗 Learn more about CSIC’s role in CancerScan: https://t.co/Y8lnPnlOZW

#CancerInnovation #ResearchCollaboration #PrecisionMedicine

[CancerScan @CancerScan_EU]

🎯Therapy response isn’t driven by cancer cells alone — it’s shaped by the tumour microenvironment and its ability to adapt.

#CancerScan identifies key TME contributors to guide patient-specific therapies.
📖 Read more: https://t.co/dyyP3TeZDP

#PersonalisedMedicine #Oncology

[CancerScan @CancerScan_EU]

During his brief visit to the University of Bielefeld Igor Balaž (@neo_vivum) worked with the bioinformatics team on #CancerScan’s transcriptomics pipeline, mapping how organoid data feeds digital twins while balancing temporal resolution against cost constraints.

[CancerScan @CancerScan_EU]

This insight from Ibane Abasolo (CSIC) captures why tumour microenvironment research is central to CancerScan’s mission.

Read more about the science behind this approach
👇https://t.co/Y8lnPnmmPu

#CancerScan #OncologyResearch #FutureOfMedicine

[CancerScan @CancerScan_EU]

🔬 TME crosstalk shapes treatment response.
Cancer adapts through continuous dialogue with its surroundings — driving resistance, immune suppression & relapse.

At #CancerScan, we map the TME using multi-omics & digital pathology.

👉Read the full article: https://t.co/dyyP3TerOh

[CancerScan @CancerScan_EU]

Tumour digital twins demand more than CPU-only computing. In #CancerScan, a heterogeneous GPU–FPGA infrastructure enables scalable, energy-efficient simulation of patient-specific tumours—bringing precision oncology closer to clinical reality. 🧬💻
#PrecisionMedicine #DigitalTwin

[CancerScan @CancerScan_EU]

The EU is unlocking secure, interoperable health data through the EHDS & Cancer Imaging Initiative. #CancerScan supports this shift with AI-driven pathology and predictive analytics.

💡Learn more: https://t.co/9pCnAATaqm

[CancerScan @CancerScan_EU]

🧠 Why is pancreatic cancer so difficult to treat?
A dense tumor microenvironment creates physical & biological barriers that limit drug penetration, boost cancer cell plasticity & fuel resistance.

Decoding this crosstalk is key — and exactly what #CancerScan tackles.

[CancerScan @CancerScan_EU]

Precision oncology needs fast, energy-efficient tumour digital twin simulation. In #CancerScan, we combine GPUs and FPGAs to accelerate image analysis and enable clinically deployable digital twins for treatment optimisation.

🔗 Read the full article: https://t.co/R0jeSWwun5

[CancerScan @CancerScan_EU]

Innovation matters only if it reaches everyone 🌍 The European Health Union + #EUCancerPlan promote equity & cross-border care. #CancerScan develops interoperable tools so all patients benefit from personalised treatment. 🏥🤝

🔍Explore further: https://t.co/1SHOcNDvZb

[CancerScan @CancerScan_EU]

“CancerScan challenges us to rethink computing as part of the clinical workflow,” says Marco Santambrogio.
Politecnico di Milano is helping bring patient-specific tumour digital twins closer to clinical use with GPU–FPGA computing.
👉https://t.co/yydjqXiIK3

@polimi #computing

[CancerScan @CancerScan_EU]

As 2025 ends, #CancerScan thanks all collaborators & partners for their support!🤝🧬
Excited to keep building patient-specific tumour digital twins & advancing precision oncology in the new year 🎄✨🚀

#DigitalPathology #CancerResearch #Innovation

[CancerScan @CancerScan_EU]

Spotlight on @VHIR_ – Vall d’Hebron Research Institute 🧬🏥

VHIR leads organoid experiments, multi-omics analysis & slide digitalization in #CancerScan, linking patient care & research to validate new biomedical technologies.

👉 https://t.co/fReCaWKiWP

#CancerResearch #health

[CancerScan @CancerScan_EU]

Meet Bielefeld University (UNIBI)🧬📘

UNIBI brings interdisciplinary expertise in AI, deep learning & multi-omics to #CancerScan, analysing tumour communication to support patient-specific digital twins.

🌐 https://t.co/HtIFgE6b9E

#DigitalHealth #EuropeanResearch #HorizonEU

[CancerScan @CancerScan_EU]

Introducing Politecnico di Milano (@polimi) - who brings expertise in engineering, AI, and medical imaging to #CancerScan, leading image analysis & segmentation for patient-specific tumour digital twins.

Bridging research & real-world healthcare.🔧🔬

🚀 https://t.co/iRhEpsjD3U

[CancerScan @CancerScan_EU]

Through @IQAC_CSIC in Barcelona, CSIC leads our patient-specific tumour digital twins project.

With strong expertise in chemical sciences, multi-omics, organoids & EU projects, they ensure rigorous data for precision cancer modelling.

👉 https://t.co/k6EPCjeTEL

#CancerScan

[CancerScan @CancerScan_EU]

How does the tumour microenvironment shape therapy resistance?

The LASIGE team at @cienciasulisboa is tackling this with AI — creating knowledge graphs and neurosymbolic models to power new cancer insights.

#AIforHealth #CancerResearch #EuropeanResearch #HorizonEurope

[CancerScan @CancerScan_EU]

Meet MINDS & SPARKS – leading communication and dissemination in #CancerScan.

This independent non-profit organisation connects science, technology & society, ensuring project insights reach clinicians, researchers & citizens. 🌍🧬

Discover their work 👉 https://t.co/LCfCtVjrR5

[CancerScan @CancerScan_EU]

Europe’s Beating Cancer Plan is transforming how we prevent, detect & treat cancer. Projects like #CancerScan support this vision by developing smarter, personalised diagnostic tools that bring innovation closer to every patient.

👉 https://t.co/dY6SIIEg7J

#EUCancerPlan #Health

[CancerScan @CancerScan_EU]

Meet Neovivum Technologies, the mind behind #CancerScan - an AI-driven project decoding how tumors communicate.

Neovivum is developing advanced cognitive systems capable of generating tumor digital twins to advance precision oncology.

👉 https://t.co/iuy0Yh2FXu